Related Experiment Video
Updated: Oct 17, 2025
12:41
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
5.2K
Data augmentation based on waterfall plots to increase value of response data generated by small single arm Phase II
Gang Han1, Lajos Pusztai2, Christos Hatzis2
1Department of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, College Station, TX, United States of America.
Contemporary Clinical Trials
|October 11, 2021
Summary
This study introduces data augmentation to improve tumor response analysis in clinical trials. Statistical summaries of augmented data offer deeper insights into antitumor activity beyond standard waterfall plots.
Area of Science:
- Oncology
- Biostatistics
- Clinical Trial Analysis
Background:
- Waterfall plots are common for visualizing tumor response in Phase II trials.
- Quantitative summaries and distribution features are often missing from waterfall plot analyses.
- This limits a comprehensive understanding of antitumor activity.
Purpose of the Study:
- To propose data augmentation using a statistical distribution system for enhanced waterfall plot analysis.
- To provide valuable statistical summaries from raw and augmented data.
- To offer additional insights into treatment effects in clinical trials.
Main Methods:
- Augmenting tumor response data with a statistical distribution system.
- Calculating summary statistics from both original and augmented datasets.
- Applying the proposed method to numerical studies and a Phase II ovarian carcinoma trial.
Main Results:
- Demonstrated the utility of augmented data for statistical summaries.
- Showcased additional insights into treatment efficacy.
- Validated the method in a real-world clinical trial setting.
Conclusions:
- Statistical analysis of augmented data provides valuable insights beyond waterfall plots.
- The proposed method enhances the understanding of antitumor activity and treatment effects.
- Recommends integrating these statistical analyses for robust clinical trial inference.
More Related Videos
07:35Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.7K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.4K
Related Concept Videos
01:11Clinical Trials: Overview
3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
01:12Analysis of Population Pharmacokinetic Data
446
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
446
01:16Clinical Trials
9.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.7K
01:13Data Collection by Experiments
25.7K
Data collection is a systematic method of obtaining, observing, measuring, and analyzing accurate information. An experimental study is a standard method of data collection that involves the manipulation of the samples by applying some form of treatment prior to data collection. It refers to manipulating one variable to determine its changes on another variable. The sample subjected to treatment is known as “experimental units.”
An example of the experimental method is a public...
An example of the experimental method is a public...
25.7K
01:03Dose-Response Relationship: Overview
4.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.1K
01:19Pharmacovigilance
1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K